- Home
- RAND vs XCUR Comparison
RAND vs XCUR Comparison
Compare RAND & XCUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAND
- XCUR
- Stock Information
- Founded
- RAND 1969
- XCUR 2011
- Country
- RAND United States
- XCUR United States
- Employees
- RAND N/A
- XCUR N/A
- Industry
- RAND Finance: Consumer Services
- XCUR Biotechnology: Pharmaceutical Preparations
- Sector
- RAND Finance
- XCUR Health Care
- Exchange
- RAND Nasdaq
- XCUR Nasdaq
- Market Cap
- RAND 47.5M
- XCUR 39.9M
- IPO Year
- RAND N/A
- XCUR N/A
- Fundamental
- Price
- RAND $17.06
- XCUR $18.40
- Analyst Decision
- RAND
- XCUR
- Analyst Count
- RAND 0
- XCUR 0
- Target Price
- RAND N/A
- XCUR N/A
- AVG Volume (30 Days)
- RAND 12.6K
- XCUR 578.3K
- Earning Date
- RAND 11-06-2024
- XCUR 11-14-2024
- Dividend Yield
- RAND 29.48%
- XCUR N/A
- EPS Growth
- RAND 123.39
- XCUR N/A
- EPS
- RAND 4.98
- XCUR N/A
- Revenue
- RAND $8,351,941.00
- XCUR $500,000.00
- Revenue This Year
- RAND N/A
- XCUR N/A
- Revenue Next Year
- RAND N/A
- XCUR N/A
- P/E Ratio
- RAND $3.42
- XCUR N/A
- Revenue Growth
- RAND 16.96
- XCUR N/A
- 52 Week Low
- RAND $12.81
- XCUR $1.44
- 52 Week High
- RAND $24.10
- XCUR $36.00
- Technical
- Relative Strength Index (RSI)
- RAND 42.96
- XCUR 51.82
- Support Level
- RAND $18.67
- XCUR $15.37
- Resistance Level
- RAND $24.10
- XCUR $19.22
- Average True Range (ATR)
- RAND 1.34
- XCUR 3.49
- MACD
- RAND -0.26
- XCUR -1.13
- Stochastic Oscillator
- RAND 9.63
- XCUR 30.37
About RAND Rand Capital Corporation
Rand Capital Corp is a closed-end, diversified management company. The firm's investment objectives is to maximize the total return to the shareholders with current income combined with capital appreciation. Some of its portfolios include lumious, and GiveGab among others.
About XCUR Exicure Inc.
Exicure Inc is a biotechnology company that develops nucleic acid therapies targeting ribonucleic acid against validated targets for neurological disorders and hair loss. It operates in a single segment, which is the discovery, research, and development of treatments based on its SNA (Spherical Nucleic Acid) technology.